SEC Form 4 · accession 0001181431-15-000496
Intra-Cellular Therapies, Inc. · ITCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Juan F. Sanchez
Officer — VP, Corp. Communications & IR
Period of report
Jan 2, 2015
Accepted (ET)
Jan 6, 2015 · 5:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567514
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $17.57 | Jan 2, 2015 | A | 30,050 | A | — | Jan 2, 2025 | Common Stock | 30,050 | 30,050 | D |
Explanation of responses
- F1The option vests as to one third of the shares on January 2, 2016, one third of the shares on January 2, 2017 and one third of the shares on January 2, 2018.